Oral AMXT 1501 Dicaprate in Combination With DFMO

Clinical trial NCT03536728 · COMPLETED

Trial details

NCT number: NCT03536728
Sponsor: Aminex Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Solid Tumor Solid Carcinoma Advanced Cancer

Start date: 2018-06-12
Primary completion: 2022-12-30
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.